193 related articles for article (PubMed ID: 35304037)
21. The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome).
Miebach E; Church H; Cooper A; Mercer J; Tylee K; Wynn RF; Wraith JE
J Inherit Metab Dis; 2011 Jun; 34(3):755-61. PubMed ID: 21416193
[TBL] [Abstract][Full Text] [Related]
22. The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I.
Broomfield A; Sims J; Mercer J; Hensman P; Ghosh A; Tylee K; Stepien KM; Oldham A; Prathivadi Bhayankaram N; Wynn R; Wright NB; Jones SA; Wilkinson S
Mol Genet Metab; 2021 Feb; 132(2):94-99. PubMed ID: 32713717
[TBL] [Abstract][Full Text] [Related]
23. Clinical manifestations and treatment of mucopolysaccharidosis type I patients in Latin America as compared with the rest of the world.
Muñoz-Rojas MV; Bay L; Sanchez L; van Kuijck M; Ospina S; Cabello JF; Martins AM
J Inherit Metab Dis; 2011 Oct; 34(5):1029-37. PubMed ID: 21541721
[TBL] [Abstract][Full Text] [Related]
24. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
[TBL] [Abstract][Full Text] [Related]
25. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.
de Ru MH; Boelens JJ; Das AM; Jones SA; van der Lee JH; Mahlaoui N; Mengel E; Offringa M; O'Meara A; Parini R; Rovelli A; Sykora KW; Valayannopoulos V; Vellodi A; Wynn RF; Wijburg FA
Orphanet J Rare Dis; 2011 Aug; 6():55. PubMed ID: 21831279
[TBL] [Abstract][Full Text] [Related]
26. Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience.
Rodgers NJ; Kaizer AM; Miller WP; Rudser KD; Orchard PJ; Braunlin EA
J Inherit Metab Dis; 2017 Mar; 40(2):271-280. PubMed ID: 28054207
[TBL] [Abstract][Full Text] [Related]
27. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic cell transplantation for Mucopolysaccharidosis I in the presence of decreased cardiac function.
Pillai NR; Elsbecker SA; Gupta AO; Lund TC; Orchard PJ; Braunlin E
Mol Genet Metab; 2023 Nov; 140(3):107669. PubMed ID: 37542767
[TBL] [Abstract][Full Text] [Related]
29. Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational study.
Muenzer J; Burton BK; Amartino HM; Harmatz PR; Gutiérrez-Solana LG; Ruiz-Garcia M; Wu Y; Merberg D; Alexanderian D; Jones SA
Orphanet J Rare Dis; 2023 Nov; 18(1):357. PubMed ID: 37974184
[TBL] [Abstract][Full Text] [Related]
30. Progression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation.
Langereis EJ; den Os MM; Breen C; Jones SA; Knaven OC; Mercer J; Miller WP; Kelly PM; Kennedy J; Ketterl TG; O'Meara A; Orchard PJ; Lund TC; van Rijn RR; Sakkers RJ; White KK; Wijburg FA
J Bone Joint Surg Am; 2016 Mar; 98(5):386-95. PubMed ID: 26935461
[TBL] [Abstract][Full Text] [Related]
31. Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome.
Pal AR; Langereis EJ; Saif MA; Mercer J; Church HJ; Tylee KL; Wynn RF; Wijburg FA; Jones SA; Bruce IA; Bigger BW
Orphanet J Rare Dis; 2015 Apr; 10():42. PubMed ID: 25887468
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry.
D'Aco K; Underhill L; Rangachari L; Arn P; Cox GF; Giugliani R; Okuyama T; Wijburg F; Kaplan P
Eur J Pediatr; 2012 Jun; 171(6):911-9. PubMed ID: 22234477
[TBL] [Abstract][Full Text] [Related]
33. Carotid intima-media thickness is increased in patients with treated mucopolysaccharidosis types I and II, and correlates with arterial stiffness.
Wang RY; Braunlin EA; Rudser KD; Dengel DR; Metzig AM; Covault KK; Polgreen LE; Shapiro E; Steinberger J; Kelly AS
Mol Genet Metab; 2014 Feb; 111(2):128-32. PubMed ID: 24268528
[TBL] [Abstract][Full Text] [Related]
34. Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndrome.
Ahmed A; Whitley CB; Cooksley R; Rudser K; Cagle S; Ali N; Delaney K; Yund B; Shapiro E
Mol Genet Metab; 2014 Feb; 111(2):123-7. PubMed ID: 24368159
[TBL] [Abstract][Full Text] [Related]
35. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
[TBL] [Abstract][Full Text] [Related]
36. Gross and fine motor skills of children with Hurler syndrome (MPS-IH) post umbilical cord blood transplantation: a case series report.
Dusing SC; Rosenberg A; Hiemenz JR; Piner S; Escolar M
Pediatr Phys Ther; 2005; 17(4):264-7. PubMed ID: 16357681
[TBL] [Abstract][Full Text] [Related]
37. Long-term neurocognitive function of pediatric patients with severe combined immune deficiency (SCID): pre- and post-hematopoietic stem cell transplant (HSCT).
Lin M; Epport K; Azen C; Parkman R; Kohn DB; Shah AJ
J Clin Immunol; 2009 Mar; 29(2):231-7. PubMed ID: 18807155
[TBL] [Abstract][Full Text] [Related]
38. A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II.
Shapiro EG; Rudser K; Ahmed A; Steiner RD; Delaney KA; Yund B; King K; Kunin-Batson A; Eisengart J; Whitley CB
Mol Genet Metab Rep; 2016 Jun; 7():32-9. PubMed ID: 27114914
[TBL] [Abstract][Full Text] [Related]
39. An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA.
Wijburg FA; Aiach K; Chakrapani A; Eisengart JB; Giugliani R; Héron B; Muschol N; O'Neill C; Olivier S; Parker S
Mol Genet Metab; 2022 Feb; 135(2):133-142. PubMed ID: 34991944
[TBL] [Abstract][Full Text] [Related]
40. "Growth patterns in children with mucopolysaccharidosis type I-Hurler after hematopoietic stem cell transplantation: Comparison with untreated patients".
Cattoni A; Chiaraluce S; Gasperini S; Molinari S; Biondi A; Rovelli A; Parini R
Mol Genet Metab Rep; 2021 Sep; 28():100787. PubMed ID: 34408967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
